Hypolipidemic and antioxidative effects of the plant glycoprotein (36 kDa) from Rhus verniciflua stokes fruit in triton WR-1339-induced hyperlipidemic mice

Bioscience, Biotechnology and Biochemistry

Volumn 70, Issue 2, 2006, Pages 447-456

  Oh, Phil Sun ^a   Lee, Sei Jung ^a   Lim, Kye Taek ^a  

^a Chonnam National University   (South Korea)

Author keywords

3 hydroxy 3 methylglutaryl CoA (HMG CoA) reductase; Detoxicant enzyme; Hypolipidemic activity; Nitric oxide; Rhus verniciflua Stokes (RVS) glycoprotein

Indexed keywords

ANTIOXIDANTS; CHOLESTEROL; FRUITS; LIPIDS; NITROGEN OXIDES; PLANTS (BOTANY);

3-HYDROXY-3-METHYLGLUTARYL COA (HMG-COA) REDUCTASE; DETOXICANT ENZYMES; HYPOLIPIDEMIC ACTIVITY; NITRIC OXIDE; RHUS VERNICIFLUA STOKES (RVS) GLYCOPROTEIN;

PROTEINS;

3 HYDROXY 3 METHYLGLUTARYL COENZYME A; 3-HYDROXY-3-METHYLGLUTARYL-COENZYME A; ACYL COENZYME A; ANTIOXIDANT; CHOLESTEROL; GLYCOPROTEIN; MACROGOL DERIVATIVE; NITRIC OXIDE; TYLOXAPOL;

ANIMAL; ARTICLE; BIOSYNTHESIS; BLOOD; CHEMICALLY INDUCED DISORDER; CHEMISTRY; DRUG EFFECT; FRUIT; HYPERLIPIDEMIA; INSTITUTE FOR CANCER RESEARCH MOUSE; LIPID PEROXIDATION; MALE; METABOLISM; MOLECULAR WEIGHT; MOUSE; PHYTOTHERAPY; POISON IVY;

ACYL COENZYME A; ANIMALS; ANTIOXIDANTS; CHOLESTEROL; FRUIT; GLYCOPROTEINS; HYPERLIPIDEMIAS; LIPID PEROXIDATION; MALE; MICE; MICE, INBRED ICR; MOLECULAR WEIGHT; NITRIC OXIDE; PHYTOTHERAPY; POLYETHYLENE GLYCOLS; RHUS;

ANTIOXIDANTS; FRUITS; LIPIDS; NITROGEN OXIDES; PLANTS; PROTEINS; STEROLS;

HEDERA; TOXICODENDRON VERNICIFLUUM;

EID: 33344469139     PISSN: 09168451     EISSN: None     Source Type: Journal    
DOI: 10.1271/bbb.70.447     Document Type: Article

References (38)

1. Lusis, A. J., Atherosclerosis. Nature, 407, 233-241 (2000).
2. Regnstrom, J., Nilsson, J., Tornvall, P., Landou, C., and Hamsten, A., Susceptibility to low-density lipoprotein oxidation and coronary atherosclerosis in man. Lancet, 339, 1183-1186 (1992).
3. Catapano, A. L., Maggi, F. M., and Tragni, E., Low density lipoprotein oxidation, antioxidants, and atherosclerosis. Curr. Opin. Cardiol., 15, 355-363 (2000).
4. Liao, J. K., Shin, W. S., Lee, W. Y., and Clark, S. L., Oxidized low-density lipoprotein decreases the expression of endothelial nitric oxide synthase. J. Biol. Chem., 270, 319-324 (1995).
5. Araujo, F. B., Barbosa, D. S., Hsin, C. Y., Maranhao, R. C., and Abdalla, D. S., Evaluation of oxidative stress in patients with hyperlipidemia. Atherosclerosis, 117, 61-71 (1995).
6. Ishii, H., Suga, T., Hayashi, H., and Niinobe, S., Effect of Triton WR-1339 on the rates of synthesis and degradation of hepatic catalase of rat. J. Biochem., 86, 1163-1166 (1979).
7. Liou, W., Chang, L. Y., Geuze, H. J., Strous, G. J., Crapo, J. D., and Slot, J. W., Distribution of CuZn superoxide dismutase in rat liver. Free Radic. Biol. Med., 14, 201-207 (1993).
8. Ismail, N. M., Abdul, Ghafar, N., Jaarin, K., Khine, J. H., and Top, G. M., Vitamin E and factors affecting atherosclerosis in rabbits fed a cholesterol-rich diet. Int. J. Food Sci. Nutr., 51, S79-94 (2000).
9. Hossain, S., Hashimoto, M., Choudhury, E. K., Alam, N., Hussain, S., Hasan, M., Choudhury, S. K., and Mahmud, I., Dietary mushroom (Pleurotus ostreatus) ameliorates atherogenic lipid in hypercholesterolaemic rats. Clin. Exp. Pharmacol. Physiol., 30, 470-475 (2003).
10. Sano, A., Yamakoshi, J., Tokutake, S., Tobe, K., Kubota, Y., and Kikuchi, M., Procyanidin B1 is detected in human serum after intake of proanthocyanidin-rich grape seed extract. Biosci. Biotechnol. Biochem., 67, 1140-1143 (2003).
11. Kim, T. J., "Korea Resource Plant" II, Seoul University Press, Seoul, pp. 292-297 (1996).
12. Lim, K. T., Lee, J. C., Jung, H. Y., and Jo, S. K., Effects of Rhus verniciflua Stokes (RVS) on cell-associated detoxificant enzymes, and glucose oxidase-mediated toxicity in cultured mouse hepatocytes. Kor. J. Toxicol. Pub. Health, 16, 125-131 (2000).
13. Ko, J. H., Lee, S. J., and Lim, K. T., 36-kDa glycoprotein isolated from Rhus verniciflua Stokes fruit has a protective activity to glucose/glucose oxidase-induced apoptosis in NIH/3T3 cells. Toxicol. In Vitro, 19, 353-363 (2005).
14. American Society of Mammalogists Animal Care and Use Committee, Guidelines for the capture, handling, and care of mammals as approved by the American Society of Mammalogists. J. Mammal., 79, 1416-1431 (1998).
15. Lee, S. J., Ko, J. H., Lim, K., and Lim, K. T., 150-kDa glycoprotein isolated from Solanum nigrum Linne enhances activities of detoxicant enzymes and lowers plasmic cholesterol in mouse. Pharmacol. Res., 51, 399-408 (2005).
16. Kusama, H., Nishiyama, M., and Ikeda, S., Pharmacological investigation of bezafibrate, a hypolipidemic agent (1). Effects of bezafibrate on normal and experimental hyperlipidemia in rats. Nippon Yakurigaku Zasshi, 92, 175-180 (1988).
17. Warnick, G. R., Benderson, J., and Albers, J. J., Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. Clin. Chem., 28, 1379-1388 (1982).
18. Burke, R. W., Diamondstone, B. I., Velapoldi, R. A., and Menis, O., Mechanisms of the Liebermann-Burchard and Zak color reactions for cholesterol. Clin. Chem., 20, 781-794 (1974).
19. Tercyak, A. M., Determination of cholesterol and cholesterol esters. J. Nutr. Biochem., 2, 281-292 (1991).
20. Edwards, P. A., Lemongello, D., and Fogelman, A. M., Improved methods for the solubilization and assay of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase. J. Lipid Res., 20, 40-46 (1979).
21. Buege, J. A., and Aust, S. D., Microsomal lipid peroxidation. Methods Enzymol., 52, 302-310 (1978).
22. Green, L. C., Wagner, D. A., Glogowski, J., Skipper, P. L., Wishnok, J. S., and Tannenbaum, S. R., Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal. Biochem., 126, 131-138 (1982).
23. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J., Protein measurement with the Folin phenol reagent. J. Biol. Chem., 193, 265-275 (1951).
24. Beauchamp, C., and Fridovich, I., Superoxide dismutase: improved assays and an assay applicable to acrylamide gels. Anal. Biochem., 44, 276-287 (1971).
25. Thomson, J. F., Nance, S. L., and Tollaksen, S. L., Spectrophotometric assay of catalase with perborate as substrate. Proc. Soc. Exp. Biol. Med., 157, 33-35 (1978).
26. Paglia, D. E., and Valentine, W. N., Studies on the quantitative and qualitative characterization of erythrocyte glutathine peroxidase. J. Lab. Clin. Med., 70, 158-169 (1967).
27. Zhou, M., Chen, Y., Ouyang, Q., Liu, S. X., and Pang, Z. J., Reduction of the oxidative injury to the rabbits with established atherosclerosis by protein bound polysaccharide from Coriolus Vesicolor. Am. J. Chin. Med., 28, 239-249 (2000).
28. Lee, S. J., Oh, P. S., Ko, J. H., Lim, K., and Lim, K. T., A 150-kDa glycoprotein isolated from Solanum nigrum L. has cytotoxic and apoptotic effects by inhibiting the effects of protein kinase C alpha, nuclear factor-kappa B and inducible nitric oxide in HCT-116 cells. Cancer Chemother. Pharmacol., 54, 562-572 (2004).
29. Lee, J. C., Jung, H. Y., and Lim, K. T., Biological function of the extracts from Ficus Carica Linnaeus (FCL). J. Toxicol. Pub. Health, 15, 353-361 (1999).
30. Friedman, M., and Byers, S. O., Mechanism underlying hypercholesteremia induced by Triton WR-1339. Am. J. Physiol, 190, 439-445 (1957).
31. Goldfarb, S., Rapid increase in hepatic HMG CoA reductase activity and in vivo cholesterol synthesis after Triton WR 1339 injection. J. Lipid Res., 19, 489-494 (1978).
32. Endo, A., Tsujita, Y., Kuroda, M., and Tanzawa, K., Effects of ML-236B on cholesterol metabolism in mice and rats: lack of hypocholesterolemic activity in normal animals. Biochim. Biophys. Acta, 575, 266-276 (1979).
33. Takahashi, Y., Inaba, N., Kuwahara, S., and Kuki, W., Effects of gamma-terpinene on lipid concentrations in serum using Triton WR1339-treated rats. Biosci. Biotechnol. Biochem., 67, 2448-2450 (2003).
34. Kim, Y. S., Jung, E. A., Shin, J. E., Chang, J. C., Yang, H. K., Kim, N. J., Cho, K. H., Bae, H. S., Moon, S. K., and Kim, D. H., Daio-Orengedokuto inhibits HMG-CoA reductase and pancreatic lipase. Biol. Pharm. Bull., 25, 1442-1445 (2002).
35. Gordon, D. J., Probstfield, J. L., Garrison, R. J., Neaton, J. D., Castelli, W. P., Knoke, J. D., Jacobs Jr., D. R., Bangdiwala, S., and Tyroler, H. A., High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation, 79, 8-15 (1989).
36. Rodwell, V. W., Cholesterol regulation of hepatic 3-hydroxy-3- methylglutaryl-coenzyme A reductase. Biochem. J., 128, 16P (1972).
37. Kurusu, A., Shou, I., Nakamura, S., Fukui, M., Shirato, I., and Tomino, Y., Effects of the new hydroxy-3-methylglutaryl coenzyme A reductase inhibitor fluvastatin on anti-oxidant enzyme activities and renal function in streptozotocin-induced diabetic rats. Clin. Exp. Pharmacol. Physiol., 27, 767-770 (2000).
38. Grundy, S. M., Ahrens Jr., E. H., and Salen, G., Interruption of the enterohepatic circulation of bile acids in man: comparative effects of cholestyramine and ileal exclusion on cholesterol metabolism. J. Lab. Clin. Med., 78, 94-121 (1971).